Colorectal Neoplasms Clinical Trials in Shenyang, Liaoning
2 recruitingShenyang, Liaoning, China
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Colorectal Neoplasms
Seagen, a wholly owned subsidiary of Pfizer400 enrolled383 locationsNCT05253651
Recruiting
Not Applicable
Health Behavior Change in High-Risk Colorectal Cancer Individuals
Colorectal NeoplasmsHealth BehaviorPrimary Prevention/Methods
China Medical University, China80 enrolled1 locationNCT07262840